Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ewa Wierbiecka-Hainaut"'
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:996-999
Introduction BRAF and MEK inhibitors have been approved for use in metastatic melanoma therapies. All of them are administered as oral capsules or pills. We report two cases treated applying an alternative method of vemurafenib or debrafenib-trametin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faf6e4d755dac650baa995caad99f3ff
https://doi.org/10.1177/1078155220953877
https://doi.org/10.1177/1078155220953877
Publikováno v:
Journal of Oncology Pharmacy Practice; Jun2021, Vol. 27 Issue 4, p996-999, 4p